DESCRIPTION provided by applicant A Phase II SBIR program of preclinical development is proposed for the development of an active specific immunotherapeutic called Cellariumandquot for treatment o ...SBIR Phase II 2016 Department of Health and Human Services National Institutes of Health
DESCRIPTION (provided by applicant): A Phase I SBIR program of preclinical development is proposed focusing on the development of an active specific immunotherapeutic called Cellarium for treatm ...SBIR Phase I 2010 Department of Health and Human Services
IN CYTU, INC.
| 6 Blackstone Valley Place
LINCOLN, RI, 02865-4257
|Socially and Economically Disadvantaged:||N|
|Number of Employees:||n/a|